4.7 Article

BDNF protects pancreatic β cells (RIN5F) against cytotoxic action of alloxan, streptozotocin, doxorubicin and benzo(a)pyrene in vitro

期刊

METABOLISM-CLINICAL AND EXPERIMENTAL
卷 65, 期 5, 页码 667-684

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2016.01.016

关键词

Brain-derived neurotrophic factor; RIN5F cells; Apoptosis; Free radicals; Anti-oxidants

资金

  1. Department of Biotechnology, New Delhi
  2. ICMR
  3. Defence Research and Development Organisation, New Delhi under RD Project [TC/2519/INM-03/2011/CARS, INM-311]

向作者/读者索取更多资源

Objective. The study was conducted to observe whether brain-derived neurotrophic factor (BDNF) has cytoprotective actions against alloxan (AL), streptozotocin (STZ), doxorubicin (DB) and benzo(a)pyrene (BP) compounds in vitro that may account for its beneficial action in diabetes mellitus. Materials and methods. This in vitro study was performed using rat insulinoma (RIN5F) cells. Possible cytoprotective action of BDNF (using pre-treatment, simultaneous and post-treatment schedules of RIN5F cells with BDNF) against the four chemicals tested was evaluated using MIT and apoptosis assays. Possible mechanism of cytoprotective action of BDNF was assessed by measuring BCl2/IKB-beta/Pdx mRNA transcripts and anti-oxidant levels in RIN5F cells. Effect of alloxan, STZ, doxorubicin and BP on the production of BDNF by RIN5F cells was also studied. Results. Results of the present study revealed that BDNF in the doses (100 ng > 50 ng > 10 ng/ml) has significant cytoprotection (P < 0.001, P < 0.01) on cytotoxic action of AL, STZ, DB and BP against rat insulinoma RINSF (5 x 10(4) cells/100 mu l) cells in vitro. It was observed that AL, STZ, DB and BP inhibited BDNF production significantly (P < 0.001) in a dose-dependent manner by RIN5F cells (0.5 x 10(6) cells/500 mu l) in vitro, while BDNF not only prevented apoptosis induced by these four chemicals but also significantly increased (P < 0.001) BCl2/IKB-beta/Pdx mRNA transcripts and restored anti-oxidant levels (P < 0.01) in RINSF cells to normal. Discussion. These results suggest that BDNF has potent cytoprotective actions, restores anti-oxidant defenses to normal and thus, prevents apoptosis and preserves insulin secreting capacity of beta cells. In addition, BDNF enhanced viability of RIN 5F in vitro. Thus, BDNF not only has anti-diabetic actions but also preserves pancreatic beta cells integrity and enhances their viability. These results imply that BDNF functions as an endogenous cytoprotective molecule that may explain its beneficial actions in some neurological conditions as well. (C) 2016 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Brain-derived neurotrophic factor and its clinical implications

Siresha Bathina, Undurti N. Das

ARCHIVES OF MEDICAL SCIENCE (2015)

Correction Endocrinology & Metabolism

BDNF protects pancreatic β cells (RIN5F) against cytotoxic action of alloxan, streptozotocin, doxorubicin and benzo(a)pyrene in vitro (vol 65, pg 667, 2016)

Siresha Bathina, Nanduri Srinivas, Undurti N. Das

METABOLISM-CLINICAL AND EXPERIMENTAL (2016)

Article Biochemistry & Molecular Biology

Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar rats

Siresha Bathina, Undurti N. Das

LIPIDS IN HEALTH AND DISEASE (2018)

Article Multidisciplinary Sciences

Effect of Polyunsaturated Fatty Acids and Their Metabolites on Bleomycin-Induced Cytotoxic Action on Human Neuroblastoma Cells In Vitro

Sailaja Polavarapu, Arul M. Mani, Naveen K. V. Gundala, Anasuya D. Hari, Siresha Bathina, Undurti N. Das

PLOS ONE (2014)

Article Medicine, Research & Experimental

Resolvin D1 Ameliorates Nicotinamide-streptozotocin-induced Type 2 Diabetes Mellitus by its Anti-inflammatory Action and Modulating PI3K/Akt/mTOR Pathway in the Brain

Siresha Bathina, Naveen K. Gundala, Poorani Rhenghachar, Sailaja Polavarapu, Anasuya D. Hari, Monika Sadananda, Undurti N. Das

ARCHIVES OF MEDICAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Resolvin D1 Decreases Severity of Streptozotocin-Induced Type 1 Diabetes Mellitus by Enhancing BDNF Levels, Reducing Oxidative Stress, and Suppressing Inflammation

Siresha Bathina, Undurti N. Das

Summary: RVD1 can prevent STZ-induced type 1 diabetes by its anti-apoptotic, anti-inflammatory, and antioxidant actions and by activating the Pdx gene that is needed for pancreatic beta cell proliferation. The study results suggest that RVD1 can alleviate the severity of type 1 diabetes through multiple pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Endocrinology & Metabolism

Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus

Elliot Ballato, Fnu Deepika, Mia Prado, Vittoria Russo, Virginia Fuenmayor, Siresha Bathina, Dennis T. Villareal, Clifford Qualls, Reina Armamento-Villareal

Summary: This study aimed to investigate the impact of glycemic control on circulating osteogenic progenitor (COP) cells and osteoclast precursors (OCP), as well as identify other potential factors. The results showed that individuals with poor long-term glycemic control had a significantly higher percentage of COP, which was positively correlated with visceral adipose tissue volume and negatively correlated with free testosterone and osteocalcin levels.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Biochemistry & Molecular Biology

Normal β-Cell Glut2 Expression Is not Required for Regulating Glucose-Stimulated Insulin Secretion and Systemic Glucose Homeostasis in Mice

Siresha Bathina, Tumininu S. Faniyan, Lauren Bainbridge, Autumn Davis, Kavaljit H. Chhabra

Summary: The role of beta-cell Glut2 in regulating insulin secretion and blood glucose levels in mice was investigated in this study. Knocking down Glut2 specifically in beta-cells did not affect glucose-stimulated insulin secretion and systemic glucose homeostasis in mice.

BIOMOLECULES (2023)

Review Biochemistry & Molecular Biology

Novel Adipokines and Their Role in Bone Metabolism: A Narrative Review

Fnu Deepika, Siresha Bathina, Reina Armamento-Villareal

Summary: The burden of obesity and osteoporosis is increasing and becoming a major public health concern. Recent evidence has identified novel adipokines that play a role in bone metabolism. Obesity, characterized by adipose tissue inflammation, negatively impacts bone health. Adipokines secreted from white adipose tissue and bone marrow adipose tissue have effects on osteoblasts and osteoclasts. Understanding the complex interplay between fat cells and bone is crucial in the context of osteoporosis. This review summarizes recent advances in the understanding of adipokines' role in bone metabolism.

BIOMEDICINES (2023)

Article Endocrinology & Metabolism

ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis

Kavaljit H. Chhabra, Siresha Bathina, Tumininu S. Faniyan, Dennis J. Samuel, Muhammad Ummear Raza, Leticia Maria de Souza Cordeiro, Gonzalo Viana Di Prisco, Brady K. Atwood, Jorge Robles, Lauren Bainbridge, Autumn Davis

Summary: This study identifies ADGRL1 as a glucose receptor in the mouse hypothalamus, which is involved in energy and glucose homeostasis in a sex-dependent manner. Targeting ADGRL1 may lead to the development of new drugs for the treatment of type 2 diabetes and obesity.

DIABETOLOGIA (2023)

Review Endocrinology & Metabolism

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis

Siresha Bathina, Reina Armamento-Villareal

Summary: Fractures associated with Type 2 diabetes (T2DM) are a public health concern in an obese and aging population. Patients with T2DM have normal or better bone mineral density but are at a higher risk for fractures. The main issue in T2DM is a reduction in bone formation due to dysfunction in osteoblast differentiation and survival. Obesity and T2DM are also associated with increased adipogenesis, potentially at the expense of reduced osteogenesis and myogenesis. Understanding the complex mechanisms involved in bone pathophysiology in obesity and T2DM is important for developing pharmacological targets to improve bone health.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Biochemistry & Molecular Biology

Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats

Siresha Bathina, Nanduri Srinivas, Undurti N. Das

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Endocrinology & Metabolism

Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation

Emilie Steinbach, Davide Masi, Agnes Ribeiro, Patricia Serradas, Tiphaine Le Roy, Karine Clement

Summary: The study of the gut microbiome is crucial for understanding and treating metabolic diseases. While research on the fecal microbiome has provided valuable insights, relying solely on this may not be enough to draw comprehensive conclusions. The microbiome in the proximal part of the small intestine may play a significant role in metabolic regulation, but further exploration is needed due to limited accessibility.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4

Evangelia Chavdoula, Vollter Anastas, Alessandro La Ferlita, Julian Aldana, Giuseppe Carota, Mariarita Spampinato, Burak Soysal, Ilaria Cosentini, Sameer Parashar, Anuvrat Sircar, Giovanni Nigita, Lalit Sehgal, Michael A. Freitas, Philip N. Tsichlis

Summary: This study reveals the important role of KDM2B in triple-negative breast cancer (TNBC). KDM2B affects cellular resistance to oxidative stress by regulating a network of genes and metabolic enzymes, in collaboration with ATF4 and MYC. Additionally, high expression of KDM2B is associated with poor prognosis in patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Statin therapy in individuals with intermediate cardiovascular risk

Joongmin Kim, Hyeongsoo Kim, Sang Hyun Park, Yura Kang, Kyungdo Han, Sang-Hak Lee

Summary: This study aimed to investigate the optimal LDL-C level after statin therapy in individuals with intermediate cardiovascular risk. The results showed that achieving LDL-C levels <120 mg/dL after statin therapy could lower the event risk.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Glucocorticoids and intrauterine programming of nonalcoholic fatty liver disease

Ze Chen, Li -Ping Xia, Lang Shen, Dan Xu, Yu Guo, Hui Wang

Summary: Accumulating evidence suggests that NAFLD has an intrauterine origin, with adverse prenatal environments and glucocorticoid exposure playing a crucial role in the developmental programming of fetal hepatic lipid metabolism. The offspring's glucocorticoid-insulin-like growth factor 1 (GC-IGF1) axis is programmed in utero, leading to postnatal catch-up growth and disrupted glucose and lipid metabolism, increasing susceptibility to NAFLD. Mismatch between intrauterine and postnatal environments can further disturb the programmed endocrine axes and accelerate the onset of NAFLD.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease

Fuwen Zuo, Youzhao Wang, Xinlei Xu, Ruihao Ding, Wei Tang, Yu Sun, Xiaojie Wang, Yan Zhang, Jichao Wu, Yusheng Xie, Min Liu, Ziying Wang, Fan Yi

Summary: This study investigates the role of CCDC92 in the pathogenesis of diabetic kidney disease (DKD). The expression of CCDC92 was found to increase in kidney biopsies from patients with DKD and was correlated with glomerular lipid accumulation. Animal studies further confirmed the induction of CCDC92 in the kidney, particularly in podocytes, and the podocyte-specific deletion of Ccdc92 ameliorated podocyte injury and lipid deposition. CCDC92 was shown to promote podocyte lipotoxicity through ABCA1 signaling-mediated lipid homeostasis. Therefore, CCDC92 may serve as a potential biomarker of podocyte injury in DKD and targeting CCDC92 could be an innovative therapeutic strategy for DKD patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Brown adipose tissue-derived metabolites and their role in regulating metabolism

Khanyisani Ziqubu, Phiwayinkosi Dludla, Sihle E. Mabhida, Babalwa U. Jack, Susanne Keipert, Martin Jastroch, Sithandiwe E. Mazibuko-Mbeje

Summary: The discovery and revival of brown adipose tissue (BAT) in adult humans have opened up new possibilities for treating obesity and metabolic diseases. BAT not only plays a role in generating heat, but also secretes signaling molecules known as batokines, which regulate overall metabolism. This review highlights the importance of BAT-derived metabolites in controlling thermogenesis, substrate metabolism, and other biological processes, as well as their potential to alleviate obesity and related metabolic complications.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)